Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05229120 · ClinicalTrials.gov registry record · NA

Improving Delay Discounting to Decrease Harsh Parenting Among Parents Receiving Substance Use Treatment

A NA study, sponsored by Henry Ford Health System.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT05229120 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05229120, a NA study, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

Parents with substance use disorders are disproportionately more likely to engage in harsh physical discipline, which can lead to serious clinical outcomes, including child maltreatment and the intergenerational transmission of addictive disorders. One mechanism linking substance use and maladaptive parenting strategies is parental delay discounting, or the tendency to value smaller, immediate rewards (such as stopping children's misbehavior via physical punishment) relative to larger, but delayed rewards (like shaping adaptive child behaviors over time). This study will examine the efficacy of implementing a low-cost, brief intervention targeting the reduction of parental delay discounting to inform broader public health efforts aimed at reducing child maltreatment and interrupting intergenerational cycles of substance abuse in traditionally underserved communities.

Interventions

  • BEHAVIORAL Episodic Future Thinking

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2022-04-07
Est. Completion 2023-03-31
Phase NA

Sponsor

Henry Ford Health System

234 total trials

What the Registry Record Tells You About NCT05229120

The ClinicalTrials.gov registry entry for NCT05229120 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Episodic Future Thinking is the first listed.

NCT05229120 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05229120 about?

NCT05229120 is a clinical study titled "Improving Delay Discounting to Decrease Harsh Parenting Among Parents Receiving Substance Use Treatment". Parents with substance use disorders are disproportionately more likely to engage in harsh physical discipline, which can lead to serious clinical outcomes, including child maltreatment and the intergenerational transmission of addictive disorders. One mechanism linking substance use and maladaptive...

What is the current status of trial NCT05229120?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2022-04-07. Estimated completion is 2023-03-31.

What interventions are being tested in trial NCT05229120?

The interventions under investigation include: Episodic Future Thinking (BEHAVIORAL).

Who is sponsoring clinical trial NCT05229120?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.